JNJ vs PODD
By Alex · Tickerpine
Johnson & Johnson vs Insulet Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | PODD |
|---|---|---|
| Price | $263.81 | $149.01 |
| Market cap | $635.07B | $10.33B |
| P/E ratio | 40.0 | 27.9 |
| ROE | 20.02% | 26.02% |
| Profit margin | 16.20% | 12.29% |
| Revenue growth | 5.90% | 23.50% |
| Dividend yield | 2.03% | 0.00% |
| Beta | 0.21 | 1.10 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs PODD in plain English
- JNJ is the bigger company — about 61.5× the market cap of PODD.
- PODD is cheaper on earnings (P/E 27.9 vs 40.0).
- PODD earns a higher return on equity (26% vs 20%).
- PODD is growing revenue faster (24% vs 6%).
- JNJ pays a dividend (2.03%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
PODD return calculator
See what $1,000 in Insulet Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.